Expression of constitutively active Nuclear-κB RelA transcription factor in blasts of acute myeloid leukemia
Authors:
- Frederico C RochaFRFrederico C Rocha
- Shishir ShishodiaSSShishir Shishodia
- L.Jeffrey MedeirosLML.Jeffrey Medeiros
- Hagop M KantarjianHKHagop M Kantarjian
- Saroj Vadhan-RajSVSaroj Vadhan-Raj
- Zeev EstrovZEZeev Estrov
- Terry L SmithTSTerry L Smith
- Martin H NguyenMNMartin H Nguyen
- Bharat B AggarwalBABharat B Aggarwal
- 1 February 2004
- journal article
- Published by Elsevier in Human Pathology
- Vol. 35 (2) , 246-253
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Disruption of differentiation in human cancer: AML shows the wayNature Reviews Cancer, 2003
- Nuclear transcription factor-κB as a target for cancer drug developmentLeukemia, 2002
- Nuclear Factor-κB Activation: A Question of Life or DeathBMB Reports, 2002
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κBJournal of Clinical Investigation, 2001
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000
- The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activationCurrent Opinion in Immunology, 1998
- NF-κB Transcription Factors Are Involved in Normal ErythropoiesisBlood, 1998
- B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated CellsJournal of Experimental Medicine, 1998
- Rel/NF-κB transcription factors and the control of apoptosisSeminars in Cancer Biology, 1997
- The control of hematopoiesis and leukemia: from basic biology to the clinic.Proceedings of the National Academy of Sciences, 1996